CollPlant Biotechnologies (CLGN) News Today $3.41 -0.26 (-7.08%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period CollPlant Holdings: Promising Pipeline Progress and Financial Stability Justify Buy Rating with $11 Price TargetNovember 29, 2024 | markets.businessinsider.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2024 Earnings Call TranscriptNovember 29, 2024 | msn.comCollPlant Biotechnologies’ Q3 2024 Financial UpdateNovember 27, 2024 | tipranks.comCollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call TranscriptNovember 27, 2024 | seekingalpha.comCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATENovember 27, 2024 | prnewswire.comCollPlant Biotechnologies's Earnings: A PreviewNovember 26, 2024 | benzinga.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONNovember 12, 2024 | prnewswire.comCompanies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In GrowthNovember 9, 2024 | finance.yahoo.comCollPlant Biotechnologies (NASDAQ:CLGN) Stock Quotes, Forecast and News SummaryOctober 13, 2024 | benzinga.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest UpdateCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 9,900 shares, a growth of 5.3% from the August 31st total of 9,400 shares. Based on an average trading volume of 12,200 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the shares of the stock are sold short.October 1, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 9,400 shares, an increase of 11.9% from the August 15th total of 8,400 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 12,800 shares, the short-interest ratio is currently 0.7 days.September 16, 2024 | marketbeat.comHC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN)CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - HC Wainwright lifted their Q3 2024 earnings per share estimates for shares of CollPlant Biotechnologies in a report released on Wednesday, August 21st. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.37)August 26, 2024 | marketbeat.comHC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - Stock analysts at HC Wainwright cut their FY2027 earnings per share estimates for CollPlant Biotechnologies in a research report issued to clients and investors on Wednesday, August 21st. HC Wainwright analyst S. Ramakanth now anticipatAugust 23, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | seekingalpha.comCracking The Code: Understanding Analyst Reviews For CollPlant BiotechnologiesAugust 21, 2024 | benzinga.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | msn.comCollPlant Biotechnologies Posts Loss In Q2 - Quick FactsAugust 20, 2024 | markets.businessinsider.comEven after rising 10% this past week, CollPlant Biotechnologies (NASDAQ:CLGN) shareholders are still down 71% over the past three yearsAugust 20, 2024 | finance.yahoo.comCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEAugust 20, 2024 | prnewswire.comCollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast ImplantsAugust 19, 2024 | prnewswire.comCollPlant Biotechnologies (NASDAQ:CLGN) Upgraded at EF Hutton Acquisition Co. IEF Hutton Acquisition Co. I raised CollPlant Biotechnologies to a "strong-buy" rating in a report on Monday.August 6, 2024 | marketbeat.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATIONAugust 6, 2024 | prnewswire.comCollPlant Biotechnologies Unveils Inaugural ESG and Sustainability ReportJuly 29, 2024 | prnewswire.comCollplant Biotechnologies Ltd (CLGN)July 28, 2024 | investing.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Significant Increase in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant increase in short interest in July. As of July 15th, there was short interest totalling 3,800 shares, an increase of 533.3% from the June 30th total of 600 shares. Based on an average trading volume of 8,000 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the company's stock are short sold.July 25, 2024 | marketbeat.comShort Interest in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Drops By 64.7%CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 600 shares, a decrease of 64.7% from the June 15th total of 1,700 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 7,600 shares, the days-to-cover ratio is currently 0.1 days.July 11, 2024 | marketbeat.comShort Interest in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Declines By 26.1%CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 1,700 shares, a drop of 26.1% from the May 31st total of 2,300 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 7,200 shares, the short-interest ratio is currently 0.2 days.July 1, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Down 66.2% in MayCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 2,300 shares, a decline of 66.2% from the May 15th total of 6,800 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 6,200 shares, the short-interest ratio is currently 0.4 days.June 12, 2024 | marketbeat.comCollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical DataJune 6, 2024 | prnewswire.comCLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024May 29, 2024 | investorplace.comCollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate UpdateMay 29, 2024 | prnewswire.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONMay 16, 2024 | prnewswire.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Drop in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 5,800 shares, a decline of 34.8% from the April 15th total of 8,900 shares. Based on an average daily trading volume, of 6,900 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the company's shares are short sold.May 12, 2024 | marketbeat.comCollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its BusinessApril 23, 2024 | finance.yahoo.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 33.3% in MarchCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 10,800 shares, an increase of 33.3% from the March 15th total of 8,100 shares. Based on an average daily trading volume, of 8,200 shares, the short-interest ratio is currently 1.3 days. Approximately 0.1% of the shares of the company are short sold.April 13, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call TranscriptApril 8, 2024 | msn.comCollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call TranscriptApril 6, 2024 | seekingalpha.comCollPlant Biotechnologies (NASDAQ:CLGN) Rating Reiterated by HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $11.00 price objective on shares of CollPlant Biotechnologies in a report on Friday.April 5, 2024 | marketbeat.comCollPlant Biotechnologies FY23 Net Loss NarrowsApril 4, 2024 | markets.businessinsider.comCLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023April 4, 2024 | msn.comUS Index Futures Rise, Oil Dips SlightlyApril 4, 2024 | msn.comCOLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEApril 4, 2024 | prnewswire.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Significant Decrease in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 8,100 shares, a drop of 13.8% from the February 29th total of 9,400 shares. Based on an average daily volume of 11,400 shares, the short-interest ratio is presently 0.7 days. Approximately 0.1% of the company's stock are short sold.March 30, 2024 | marketbeat.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONMarch 26, 2024 | finance.yahoo.comCollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on WednesdayCollPlant Biotechnologies (NASDAQ:CLGN) will be releasing earnings on Wednesday, March 27, Yahoo Finance reports.March 26, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 20.5% in FebruaryCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 9,400 shares, an increase of 20.5% from the February 14th total of 7,800 shares. Approximately 0.1% of the company's shares are sold short. Based on an average daily trading volume, of 14,000 shares, the days-to-cover ratio is presently 0.7 days.March 15, 2024 | marketbeat.comCollPlant Issues Letter to ShareholdersFebruary 15, 2024 | finance.yahoo.comCollPlant Issues Letter to ShareholdersFebruary 15, 2024 | prnewswire.comCOLLPLANT BIOTECH. IS-,01 (CPT.MU)February 13, 2024 | au.finance.yahoo.comCollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, CaliforniaJanuary 8, 2024 | finance.yahoo.com Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner. So please click here to see the details because a lot of people could get rich. CLGN Media Mentions By Week CLGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLGN News Sentiment▼0.000.60▲Average Medical News Sentiment CLGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLGN Articles This Week▼01▲CLGN Articles Average Week Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BrainsWay News Today Pro-Dex News Today Nevro News Today Sensus Healthcare News Today Jin Medical International News Today TriSalus Life Sciences News Today TELA Bio News Today Fractyl Health News Today FONAR News Today Monogram Orthopaedics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
